JAZZ Earnings

Quarterly EPS
$3.50
Q3 2024
$3.16
Q4 2024
$-1.52
Q1 2025
$-11.74
Q2 2025
$4.14
Q3 2025
$3.33
Q4 2025
$4.73
Q1 2026
$3.05
Q2 2026
Latest Revenue1.2B
Latest Net Income192.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$3.051.2B192.8M+15.5%+126.0%
Q1 2026$4.731.1B293.1M+19.1%+411.2%
Q4 2025$3.331.2B203.5M+10.1%+5.4%
Q3 2025$4.141.1B251.4M+6.7%+18.3%
Q2 2025-$11.741.0B-718500000+2.1%-538.1%
Q1 2025-$1.52897.8M-92500000-0.5%-560.9%
Q4 2024$3.161.1B191.1M+7.5%+110.7%
Q3 2024$3.501.1B215.1M+8.5%+50.2%
Q2 2024$2.681.0B168.6M
Q1 2024-$0.23902.0M-14618000
Q4 2023$1.501.0B94.2M
Q3 2023$2.33972.1M146.8M
Jazz Pharmaceuticals (JAZZ) — Earnings